Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $312.16 | 7 | 61.0% |
| Education | $199.98 | 2 | 39.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $243.55 | 4 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $187.37 | 2 | $0 (2017) |
| VYNE Pharmaceuticals Inc. | $53.00 | 1 | $0 (2021) |
| Lilly USA, LLC | $14.19 | 1 | $0 (2020) |
| PFIZER INC. | $14.03 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $96.57 | 3 | VYNE Pharmaceuticals Inc. ($53.00) |
| 2020 | $114.18 | 2 | Janssen Biotech, Inc. ($99.99) |
| 2017 | $301.39 | 4 | Janssen Scientific Affairs, LLC ($187.37) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/06/2021 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Immunology | ||||||
| 02/02/2021 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Immunology | ||||||
| 01/18/2021 | VYNE Pharmaceuticals Inc. | ZILXI (Drug) | Food and Beverage | In-kind items and services | $53.00 | General |
| Category: Treatment of Rosacea | ||||||
| 11/11/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 10/29/2020 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Immunology | ||||||
| 09/14/2017 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $83.83 | General |
| Category: Immunology | ||||||
| 09/11/2017 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 08/03/2017 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $103.54 | General |
| 07/26/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 833 | 1,115 | $244,861 | $116,874 |
| 2022 | 8 | 883 | 1,213 | $176,522 | $119,374 |
| 2021 | 7 | 747 | 1,029 | $123,599 | $98,059 |
| 2020 | 7 | 621 | 853 | $109,598 | $83,956 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 263 | 486 | $94,770 | $50,593 | 53.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 199 | 205 | $52,685 | $23,061 | 43.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 91 | 93 | $35,061 | $14,036 | 40.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 150 | 181 | $24,616 | $12,461 | 50.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $15,792 | $7,024 | 44.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 49 | $12,397 | $5,406 | 43.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 53 | $9,540 | $4,293 | 45.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 224 | 437 | $56,196 | $38,747 | 69.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 164 | 171 | $41,816 | $28,005 | 67.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 154 | 160 | $28,682 | $18,199 | 63.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 185 | 263 | $23,081 | $16,189 | 70.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 62 | $9,988 | $7,115 | 71.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 52 | $6,117 | $4,110 | 67.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $6,483 | $3,912 | 60.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 16 | 16 | $2,375 | $1,911 | 80.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 11 | 14 | $1,027 | $825.41 | 80.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 11 | 11 | $758.90 | $361.30 | 47.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 220 | 396 | $42,202 | $33,469 | 79.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 118 | 120 | $24,517 | $19,627 | 80.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 151 | 158 | $22,102 | $17,634 | 79.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 118 | $11,641 | $9,006 | 77.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 108 | 142 | $10,584 | $8,412 | 79.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 45 | $6,301 | $4,891 | 77.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 23 | 23 | $3,206 | $2,602 | 81.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $1,948 | $1,581 | 81.2% |
About Dr. Lucy Cheng, M.D
Dr. Lucy Cheng, M.D is a Infectious Disease healthcare provider based in Ridgewood, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1942509625.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lucy Cheng, M.D has received a total of $512.14 in payments from pharmaceutical and medical device companies, with $96.57 received in 2021. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($312.16).
As a Medicare-enrolled provider, Cheng has provided services to 3,084 Medicare beneficiaries, totaling 4,210 services with total Medicare billing of $418,263. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease
- Location Ridgewood, NJ
- Active Since 03/21/2011
- Last Updated 07/10/2018
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1942509625
Products in Payments
- STELARA (Biological) $183.82
- TREMFYA (Drug) $143.56
- ZILXI (Drug) $53.00
- TALTZ (Drug) $14.19
- ELIQUIS (Drug) $14.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Ridgewood
Neil Gaffin, M.d, M.D
Infectious Disease — Payments: $6,377
Deborah Rudin, M.d, M.D
Infectious Disease — Payments: $313.25
Carol Sotsky, M.d, M.D
Infectious Disease — Payments: $199.43
Dr. Simon Tsiouris, M.d, M.D
Infectious Disease — Payments: $113.52
Dr. Tosca Kinchelow, Md, MD
Infectious Disease — Payments: $49.35
Dr. John Riefler, M.d, M.D
Infectious Disease — Payments: $36.03